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Abstract
Background: Typical symptoms and signs of a clinical condition may be absent in spinal cord injury
(SCI) patients.
Case presentation: A male with paraplegia was passing urine through penile sheath for 35 years,
when he developed urinary infections. There was no history of haematuria. Intravenous urography
showed bilateral hydronephrosis. The significance of abnormal outline of bladder was not appreciated.
As there was large residual urine, he was advised intermittent catheterisation. Serum urea: 3.5 mmol/
L; creatinine: 77 umol/L. A year later, serum urea: 36.8 mmol/l; creatinine: 632 umol/l; white cell
count: 22.2; neutrophils: 18.88. Ultrasound: bilateral hydronephrosis. Bilateral nephrostomy was
performed. Subsequently, blood tests showed: Urea: 14.2 mmol/l; Creatinine: 251 umol/l; Adjusted
Calcium: 3.28 mmol/l; Parathyroid hormone: < 0.7 pmol/l (1.1 – 6.9); Parathyroid hormone-related
protein (PTHrP): 2.3 pmol/l (0.7 – 1.8). Ultrasound scan of urinary bladder showed mixed
echogenicity, which was diagnosed as debris. CT of pelvis was interpreted as vesical abscess. Urine
cytology: Transitional cells showing mild atypia. Bladder biopsy: Inflamed mucosa lined by normal
urothelial cells.
A repeat ultrasound scan demonstrated a tumour arising from right lateral wall; biopsy revealed
squamous cell carcinoma. In view of persistently high white cell count and high calcium level,
immunohistochemistry for G-CSF and PTHrP was performed. Dense staining of tumour cells for G-
CSF and faintly positive staining for C-terminal PTHrP were observed. This patient expired about five
months later.
Conclusion: This case demonstrates how delay in diagnosis of bladder cancer could occur in a SCI
patient due to absence of characteristic symptoms and signs.
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Background
In the patients with spinal cord injury (SCI), diagnosis of
a clinical condition may be delayed because these patients
do not manifest traditional symptoms and signs. For ex-
ample, the symptoms and signs of hydronephrosis due to
urinary calculus may be bizarre and non-specific in SCI
patients. [1]. In a tetraplegic patient, pyonephrosis with
perinephric abscess was detected only during autopsy. [1].
We experienced problems in early diagnosis of bladder
cancer in a SCI patient due to difficulties in interpretation
of intravenous urography, ultrasound scan of urinary
bladder and CT of pelvis, and failure to recognise the sig-
nificance of persistently high white cell count and elevat-
ed C-reactive protein.
Bladder cancer may very rarely produce granulocyte colo-
ny stimulating factor (G-CSF). [2–9]. Kawanishi and asso-
ciates [9] described a 84-year-old male with bladder
cancer in whom, the white cell count was 46,900/mm3 in
the peripheral blood and G-CSF was 226 pg/ml (normal:
30 pg/ml). The leucocyte count in the peripheral blood re-
turned to the normal range after resection of the tumour
(partial cystectomy). But leucocytosis recurred one month
post-operatively and CT scan revealed intrapelvic tumour
recurrence.
Bladder cancer has been shown to produce parathyroid
hormone related protein (PTHrP), albeit very rarely.
[10,11]. Simultaneous production of both G-CSF and
PTHrP is extremely uncommon. [12–14]. The gene encod-
ing G-CSF and PTHrP is in the long arm of chromosome
17 and the short arm of chromosome 12, respectively.
[12]. It is possible that there might be a specific abnormal-
ity in these chromosomes for simultaneous production of
G-CSF and PTHrP.
We report a SCI patient who presented with recurrent uri-
nary infection. The white cell count was high and calcium
level in peripheral blood was raised. Bladder tumour was
discovered and immunohistochemistry revealed positive
immunostaining for G-CSF and PTHrP.
We believe that this case represents the first report of blad-
der cancer in a SCI patient with simultaneous production
of G-CSF and PTHrP.
Case presentation
This male patient sustained complete traumatic paraple-
gia below T-5, at the age of six years when he was run over
by a car in June 1965. He had penile sheath drainage. In-
travenous urography (10/11/1994) showed normal kid-
neys, pelvicalyceal systems and ureters. There was a
bladder diverticulum on the left side. He was doing well
for 35 years. Then he started getting recurrent urinary in-
fection. There was no history of passing blood in urine. In-
travenous urography (24/07/2000) showed bilateral
hydronephrosis, and hydroureter, more marked on the
right side. The bladder outline was noted to be abnormal.
(Figure 1). Since large amount of residual urine resulted in
dilution of the contrast in the urinary bladder, further di-
agnostic information could not be obtained. This patient
was advised to perform intermittent catheterisation in or-
der to achieve complete, low-pressure emptying of urinary
bladder. Serum urea was 3.5 mmol/L; creatinine: 77
umol/L. The significance of abnormal outline of the right
side of the urinary bladder was not fully appreciated at
that time.
A follow-up intravenous urography (23/10/2000)
showed normal left kidney and ureter. But there was no
excretion of contrast by the right kidney. Neither ultra-
sound scan of urinary bladder, nor cystoscopy, was per-
formed at this stage. A MAG-3 renogram was requested to
assess differential kidney function. MAG 3 renogram,
which was performed on 18/06/2001, showed evidence
Figure 1
Intravenous urography (24/07/2000) -3 hours and 40 minutes
film shows very faint opacification of right renal pelvis; left
renal pelvis is slightly dilated. Bladder outline is irregular on
the right side.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/8
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of a cold area presumably corresponding to the right hy-
dronephrotic kidney. Very little function was demonstrat-
ed in the left renal area. The nuclear medicine physician
alerted that the patient had renal failure. On 18 June
2001, serum urea was 36.8 mmol/L; creatinine: 632
umol/L. Results of blood tests (urea, creatinine, calcium,
C-reactive protein, white cell count, neutrophils, and ad-
justed calcium) from 03/07/2000 to 28/11/2001, are
shown in seven charts in additional file 1.
Bilateral percutaneous right nephrostomy was performed.
Following nephrostomy drainage, blood tests showed:
Urea: 14.2 mmol/l; Creatinine: 251 umol/l; Calcium: 2.92
mmol/l; Adjusted Calcium: 3.28 mmol/l; Parathyroid
hormone: < 0.7 pmol/l (1.1 – 6.9); PTHrP: 2.3 pmol/l
(0.7 – 1.8).
Ultrasound scan of urinary bladder (29/06/2001) showed
mixed echogenicity in bladder and the presence of debris
or turbid urine was suspected; impression was chronic in-
fection. Chest X-ray showed clear lungs. Urinary cytology
(05/07/2001) revealed occasional small clusters of transi-
tional cells and these showed mild atypia consistent with
regenerative or inflammatory atypia. (Figure 2). The ap-
pearances were predominantly those of a purulent blad-
der washout with occasional mildly atypical epithelial
cells probably representing no more than inflammation
or regeneration and there was no convincing evidence of
neoplasia.
Cystoscopy was performed and biopsy was taken on 05/
07/2001. Histology showed moderately inflamed transi-
tional cell mucosa including one or two small papillary
processes, which were lined by normal urothelial cells.
There was no cytological atypia and no evidence of squa-
mous carcinoma. A CT of pelvis showed a 10 ×  6 cm "le-
sion" within the urinary bladder containing pockets of air;
appearances were those of inflammatory process with ab-
scess formation. Bone scan showed dislocation of left hip;
avascular necrosis of right humeral head; no osseous me-
tastases. A repeat ultrasound scan of urinary bladder (04/
07/2001) demonstrated an 8 ×  6 cm diameter tumour
Figure 2
Urinary cytology (05/07/2001): Section of the clot present in the specimen contains a cluster of mildly atypical transitional cells
interpreted as showing regenerative changes only, surrounded by purulent exudate.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/8
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arising from the floor and right lateral wall, which on col-
our Doppler imaging was seen to be moderately vascular.
(Figure 3). Transurethral resection was attempted on 27/
07/2001. But it was not successful due to bleeding and
consequent poor visibility. The bladder was fixed. There-
fore, suprapubic cystostomy was performed. The bladder
contained necrotic tumour. Debulking was done.
Histopathology revealed necrotic, keratinising, invasive,
moderately differentiated, squamous carcinoma of the
bladder. (Figure 4). Where present, the overlying intact
epithelium showed squamous metaplasia, with dysplasia
up to and including squamous carcinoma in situ. The
small amount of identifiable muscle present was infiltrat-
ed by tumour, which was therefore, at least stage pT2a,
and almost certainly pT2b or worse.
He developed a fistula at the site of suprapubic cystosto-
my. This patient received intravenous infusion of 60 mg of
disodium pamidronate at periodic intervals to control hy-
percalcemia. He was not considered suitable for radio-
therapy or chemotherapy. He had a progressive downhill
course and expired about five months after bladder cancer
was diagnosed.
Immunohistochemistry for G-CSF and PTHrP
In view of persistently high white cell count and high cal-
cium level, immunohistochemistry of tumour tissue for
both G-CSF and PTHrP was performed independently in
two reputed laboratories. Experienced pathologists of in-
ternational standing interpreted the slides of immuno-
staining, and they were unaware of each other's findings.
Figure 3
Repeat ultrasound of urinary bladder (04/07/2001) shows 8 cm ×  6 cm tumour arising from the floor and right lateral wall,
which on colour Doppler imaging was seen to be moderately vascular.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/8
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An immunohistochemical examination of tumour biopsy
for both G-CSF and PTHrP was done in Kidney Disease
Centre, Saitama Medical School, 38 Morohongo, Mo-
royamamachi, Iruma, Saitama 3500495, Japan, on paraf-
fin-embedded thin sections. Anti human C-PTHrP sheep
serum (109–141, provided by Daiichi Radioisotope Lab-
oratories Ltd., Tokyo, Japan) and anti-human G-CSF rab-
bit serum (provided by Chugai Pharmaceutical Co. Ltd.,
Tokyo, Japan) were used as primary antibodies. Biotin-
rabbit anti sheep IgG (Zymed Laboratories, Inc., CA,
U.S.A.), and ENVISION Polymer (peroxidase labelled pol-
ymer conjugated to anti-mouse and anti-rabbit Immu-
noglobulins, DAKO, CA, U.S.A.) served as second
antibodies, respectively. The sections were subjected to
immunostaining using a Histofine DAB substrate kit
(Nichirei Co. Ltd., Tokyo, Japan).
Immunohistochemistry for both G-CSF and PTHrP were
carried out on formalin-fixed, paraffin embedded, thin
sections of tumour biopsy in the Department of Patholo-
gy, Saiseikai Central Hospital, Minatoku, Tokyo, Japan,
with the following antibodies. The antibody for PTHrP
was purchased from the Biogenesis Ltd. England, U.K.
(Catalogue number 7170–9208). Anti rG-CSF rabbit pol-
yclonal antibody (Lot number V-1-9) was obtained from
the Chugai Pharmaceutical Company, Tokyo, Japan. The
scientists in both laboratories were not aware that immu-
nohistochemistry for G-CSF and PTHrP were being carried
out in another laboratory for confirmation.
Thus two laboratories carried out immunohistochemistry
for both G-CSF and PTHrP, and the results of immunos-
taining for G-CSF and PTHrP were consistent. G-CSF was
distributed in the major population of neoplastic cells.
Figure 5 represents immuno-histochemistry for G-CSF,
which was carried out in the Kidney Disease Centre, Saita-
ma Medical School, 38 Morohongo, Moroyamamachi,
Iruma, Saitama 3500495, Japan. Figure 6 shows immuno-
histochemistry for G-CSF, which was performed in De-
partment of Pathology, Saiseikai Central Hospital, Mina-
toku, Tokyo, Japan.
Immunohistochemistry for PTHrP showed positive im-
munostaining for C-terminal PTHrP in the tumour cells,
Figure 4
Haematoxylin & eosin staining of tumour biopsy showed well-differentiated invasive squamous carcinoma, keratinising in areasBMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/8
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albeit less dense than G-CSF. Figure 7 shows immuno-his-
tochemistry for PTHrP, which was carried out in the Kid-
ney Disease Centre, Saitama Medical School, 38
Morohongo, Moroyamamachi, Iruma, Saitama 3500495,
Japan. Figure 8 represents immuno-histochemistry for
PTHrP, which was performed in Department of Patholo-
gy, Saiseikai Central Hospital, Minatoku, Tokyo, Japan.
Estimation of G-CSF and interleukin-8 (IL-8) in blood
Since this patient had elevated white cell count, G-CSF
and IL-8 were estimated in blood on two occasions. Seven
ml of blood was taken in a gel-free heparinised tube for es-
timation of G-CSF, and IL-8. Plasma was separated in a re-
frigerated centrifuge. The plasma sample was stored at -20
degrees Celsius and transported within 72 hours on dry
ice to Division of Immunobiology, National Institute for
Biological Standards and Control, Blanche Lane, South
Mimms, Potters Bar, England. IL-8 levels in the plasma
were estimated using an ELISA as described previously
[15]. G-CSF was measured by bioassay using the GNFS-60
cell-line[16].
Results of bioassay for G-CSF and ELISA for IL-8 revealed
that the plasma levels of G-CSF and IL-8 were below de-
tectable limits.
Discussion
Receptors of G-CSF have been confirmed on the cell sur-
faces of several non-haematopoietic cell types, including
bladder cancer cells. Tachibana and associates determined
the expression of receptors of granulocyte colony stimu-
lating factor (G-CSFR) in five different human bladder
cancer cell lines and 26 primary bladder cancers. Three,
out of the five cultured cell lines, exhibited G-CSFR mRNA
signals when the reverse transcriptase polymerase chain
reaction (RT-PCR) method was used. With in situ RT-PCR,
the tumour cells of 6 out of 26 primary bladder tumour
specimens (23.1%) presented positive G-CSFR mRNA sig-
nals [17].
Figure 5
Immuno-histochemistry for G-CSF was performed in the Kidney Disease Centre, Saitama Medical School, 38 Morohongo,
Moroyamamachi, Iruma, Saitama 3500495, Japan. There is positive immunostaining for G-CSF in neoplastic cells.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/8
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G-CSF produced by non-haematopoietic malignant cells
has been reported to be capable of inducing a leukemoid
reaction in the host through intense stimulation of leuco-
cyte production. This is illustrated by the case of a 76-year-
old man who had a metastatic transitional cell carcinoma
of the urinary bladder and who demonstrated marked leu-
cocytosis, his peripheral blood leucocyte count was
94,900 leucocytes/mm3, his serum G-CSF level was 103
pg/ml. The culture medium in which the cancer cells were
grown exclusively contained a significant amount of G-
CSF (5560 pg/ml) [18]. G-CSF production in human
bladder cancer is most frequently associated with aggres-
sive tumour cell growth and a poor clinical outcome. [19].
Sadly, poor prognosis of C-GSF-producing bladder tu-
mour became true in our patient. The bladder cancer
showed positive immunostaining for G-CSF, and he died
about five months after bladder cancer was diagnosed.
What did we learn from this case?
1. The cardinal symptom of vesical malignancy is haema-
turia. But this typical feature of bladder cancer was absent
in this SCI patient. Amongst seventeen SCI patients in
whom bladder cancer was detected at the Memphis Veter-
ans Affairs Hospital during a surveillance programme for
vesical malignancy, seven patients did not have haematu-
ria. [20]. This patient did not pass blood in urine at any
time. Therefore, we failed to appreciate the significance of
abnormal outline of the right side of the urinary bladder
and did not suspect bladder cancer in intravenous urogra-
phy.
2. This SCI patient with bladder cancer presented with re-
current urinary infection. We did not perform cystoscopy
during this patient's initial visits to the hospital. We have
learnt lessons from this case and now we perform cystos-
copy in the following categories of SCI patients:
 SCI patients with abnormal bladder outline as demon-
strated by ultrasound examination, or by intravenous
urography.
Figure 6
Immuno-histochemistry for G-CSF was performed in Department of Pathology, Saiseikai Central Hospital, Minatoku, Tokyo,
Japan. There is positive immunostaining for G-CSF in tumour cells.
!BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/8
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 SCI patients with hydronephrosis as demonstrated by
ultrasound scan
 SCI patients with unilateral non-visualisation of kid-
ney in whom the previous intravenous urography showed
normal upper tracts.
 SCI patients in whom upper tract dilatation persists
even after instituting a regimen of regular intermittent
catheterisation.
 SCI patients with recurrent urinary infection.
 SCI patients who pass blood in urine
Cystoscopy to screen for squamous cell cancer of the blad-
der in spinal cord injured patients with chronic or recur-
rent urinary tract infection resulted in an earlier stage at
diagnosis and appears to convey a survival advantage.
[21]. But the cost effectiveness of cystoscopy in SCI pa-
tients with recurrent urinary infection needs to be assessed
as recurrent urinary infection is not uncommon in SCI pa-
tients.
3. Typical symptoms of bladder cancer were absent in this
SCI patient. This patient had elevated C-reactive protein,
and persistently high white cell count. Initially, we attrib-
uted high white cell count and C-reactive protein to uri-
nary infection and prescribed repeated courses of
antibiotics. We made a wrong diagnosis of debris in ultra-
sound scan of the urinary bladder; we interpreted CT of
pelvis as showing vesical abscess. Only when high white
cell count persisted despite treatment with multiple cours-
es of antibiotics, we realised that high white cell count
could be tumour related, and then performed immunos-
taining of tumour tissue for G-CSF. Lo and behold, immu-
Figure 7
Immuno-histochemistry for PTHrP was performed in the Kidney Disease Centre, Saitama Medical School, 38 Morohongo,
Moroyamamachi, Iruma, Saitama 3500495, Japan. There is positive immunostaining for C-terminal PTHrP in neoplastic cells.
!
!
!
!
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nostaining for G-CSF was positive. Health professionals
from various disciplines worked together to reach the cor-
rect diagnosis of bladder cancer producing both PTHrP
and G-CSF. We learn that a joint team approach in reach-
ing a diagnosis, and in implementing a treatment regime,
is likely to reduce delays in diagnosis and improve the
quality of care of SCI patients [22].
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